Malcisbo is a biopharmaceutical company that develops carbohydrate-based vaccines against parasitic and bacterial diseases.

We are based with our laboratories and offices in Schlieren, Switzerland.

Malcisbo is a growing company dedicated to offering a challenging work environment to highly motivated, bright, and committed individuals that join our team.

No vacancies at the moment.


Latest News

  • 26 November 2018

    VetBioNet grant

    Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

  • 25 January 2017

    Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

  • 21 December 2016

    Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.